Results 221 to 230 of about 326,583 (330)

When Compensation Becomes Unsustainable: Rethinking Medical Liability in ENT. [PDF]

Turk Arch Otorhinolaryngol
Erdağ TK.
europepmc   +1 more source

The Expert Deposes, but the Court Disposes: The Concept of Malingering and the Function of a Medical Expert Witness in the Forensic Process

, 1995
Danuta Mendelson
openalex   +1 more source

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

'Plurality’, verbal expert witness evidence to Competition Commission Inquiry into BskyB/ITV share acquisition

, 2019
Emily Bell, Stewart Purvis, Donald Trelford, Dominic Wring   +3 more
openalex   +1 more source

Fluid and Neuroimaging Biomarkers in Microgliopathy Colony‐Stimulating Factor‐1 Receptor‐Related Disorders

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela, Madison Reeves, Karen Jansen‐West, Judith Dunmore, Yuping Song, Audrey Strongosky, Sunil Gandhi, Gilana Pikover, Matt Blurton‐Jones, Robert C. Spitale, Erik H. Middlebrooks, Leonard Petrucelli, Mercedes Prudencio, Zbigniew K. Wszolek   +13 more
wiley   +1 more source

Recommendations for victim survivability assessment methodology based on the Manchester Arena Bombing Inquiry. [PDF]

Forensic Sci Int Synerg
Ballard M, Bull AMJ, Clasper JC, Hepper AE, Kirkman E, Mahoney PF.   +5 more
europepmc   +1 more source

Navigating Some Deep and Troubled Jurisprudential Waters: Lawyer–Expert Witnesses and the Twin Dangers of Disguised Testimony and Disguised Advocacy [PDF]

, 2016
W. William Hodes
openalex  

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer, Frauke Stascheit, Maximilian Mönch, Paolo Doksani, Carla Dusemund, Meret Herdick, Philipp Mergenthaler, Maike Stein, Amani Suboh, Jutta Schröder‐Braunstein, Guido Wabnitz, Jan D. Lünemann, Sophie Lehnerer, Sarah Hoffmann, Andreas Meisel   +14 more
wiley   +1 more source

Transformation of the tobacco product market in Japan, 2011-2023. [PDF]

Tob Control
Cummings KM, Roberson A, Levy DT, Meza R, Warner KE, Fong GT, Xu SS, Gravely S, Dhungel B, Borland R, O'Connor RJ, Goniewicz ML, Sweanor DT.   +12 more
europepmc   +1 more source

Expert witness report to the Frankston bypass panel: main report [PDF]

, 2009
Zeibots, ME
core